Genetic Testing Could Reshape Emergency Prescribing, but the Evidence Is Not There Yet
A new perspective argues that pharmacogenomic testing could improve emergency department prescribing, but no randomized controlled trials have yet tested ...
Tag: CYP2C19
Estimating metabolic pathway overlap in precision oncology: integrating pharmacogenetics and polypharmacy
Only a small fraction of the drugs recommended for gastrointestinal cancers are directly steered by known pharmacogenetic variants, yet the ...
Model finds CYP2C19-guided DAPT cost-effective after PCI
A 40-year NHS cost-effectiveness model estimated that CYP2C19-guided dual antiplatelet therapy after PCI was likely cost-effective for STEMI and UA/NSTEMI ...
Clopidogrel Resistance in Stroke Patients: Israeli Study Finds No Ethnic Divide
When a patient survives an ischemic stroke or a transient ischemic attack, one of the most important questions becomes deceptively ...
Cheap Two-Pill Combo Halves Early Stroke Worsening in Landmark Chinese Trial
A multicenter Chinese randomized trial found that low-dose ticagrelor plus aspirin halved early neurological deterioration after high-risk minor stroke compared ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!